(Q40284667)

English

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance

scientific article published on June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance (English)

1 reference

Europe PubMed Central

19 September 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helen Petousis-Harris

1

object named as

Helen Petousis-Harris

1 reference

Europe PubMed Central

19 September 2017

3

object named as

Nikki Turner

1 reference

Europe PubMed Central

19 September 2017

author name string

Tracey Poole

2

1 reference

Europe PubMed Central

19 September 2017

Gary Reynolds

4

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

1 June 2012

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

30

1 reference

Europe PubMed Central

19 September 2017

4945-4952

1 reference

Europe PubMed Central

19 September 2017

33

1 reference

Europe PubMed Central

19 September 2017

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Guillain-Barré syndrome following influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Safety of the trivalent inactivated influenza vaccine among children: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Vaccines for preventing influenza in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Pediatric influenza immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Studies on convulsive disorders in young children. I. Incidence of febrile and nonfebrile convulsions by age and other factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

The prevalence and incidence of convulsive disorders in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Influenza-associated illness is an important contributor to febrile convulsions in Danish children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Responses to one or two doses of a deoxycholate subunit influenza vaccine in a primed population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Adverse events associated with 2010 CSL and other inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Anthrax vaccine: short-term safety experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.052

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.05.052

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40284667&oldid=2144612634"